Important: Demonstration Site

This PEUGIC project portal is a mock-up for demonstration purposes. It only contains made-up patient data; you MUST NOT enter real data here.

Patient data

The following information is to allow identification of your patient.
Patient name
[Generated in the live system]
NHS number
[Generated in the live system]
Date of birth
[Generated in the live system]
Sex
[Generated in the live system]
Cancer site
[Generated in the live system]

For the complete list of cancer sites included in the PEUGIC project click here.

Cancer histology
[Generated in the live system]

For the complete list of cancer histologies included in the PEUGIC project click here.

Cancer diagnosis date
[Generated in the live system]

For details on how this is defined click here.

Cancer diagnosis trust
[Generated in the live system]

For details on how this is defined click here.

Cancer diagnosis hospital
[Generated in the live system]
Case registration status
[Generated in the live system]

For details on the types of registration status click here.

Index endoscopy date
[Generated in the live system]

For the definition of index endoscopy click here.

Index endoscopy trust
[Generated in the live system]
Index endoscopy hospital
[Generated in the live system]

Patient data (cont.)

Please provide further information about the patient.

These are all known to be associated with PEUGIC.

Cancer details

Please provide further information on the diagnosed cancer.

For an explanation on Siewert classification click here.

Select poorest if mixed.

For guidance on T staging click here.

For guidance on N staging click here.

For guidance on M staging click here.

For guidance on Overall staging click here.

Please provide information on the endoscopy performed closest to the cancer diagnosis date.

Please provide information on the endoscopy closest to the cancer diagnosis date.

Hierarchy of preferred measurements: Pathology report > Imaging report > Endoscopy report. If there has been neoadjuvant therapy, initial imaging measure preferred over endoscopic measurement.

Index endoscopy details

Please provide further information on the index endoscopy (the most recent non-diagnostic endoscopy performed 3-36 months prior to cancer diagnosis).

Insert time in 24-hour time format.

If more than one endoscopist, please provide name of the endoscopist responsible for or supervising the procedure.

For example, 1234567 or 12A3456A. For tips on how to find this and an explanation on why we are asking for this click here.

Polypoid: 0-Is (protruded, sessile); 0-Ip (protruded, pedunculated). Non-polypoid: 0-IIa (superficial, elevated); 0-IIb (flat); 0-IIc (superficially depressed); 0-III (excavated, ulcerated).

Please do not provide patient identifiable information.

Polypoid: 0-Is (protruded, sessile); 0-Ip (protruded, pedunculated). Non-polypoid: 0-IIa (superficial, elevated); 0-IIb (flat); 0-IIc (superficially depressed); 0-III (excavated, ulcerated).

Please do not provide patient identifiable information.

Polypoid: 0-Is (protruded, sessile); 0-Ip (protruded, pedunculated). Non-polypoid: 0-IIa (superficial, elevated); 0-IIb (flat); 0-IIc (superficially depressed); 0-III (excavated, ulcerated).

Please do not provide patient identifiable information.

Polypoid: 0-Is (protruded, sessile); 0-Ip (protruded, pedunculated). Non-polypoid: 0-IIa (superficial, elevated); 0-IIb (flat); 0-IIc (superficially depressed); 0-III (excavated, ulcerated).

Please do not provide patient identifiable information.

To facilitate root cause analysis we suggest users copy & paste free text from report. If not possible then record relevant aspects of the procedure not captured by the root cause analysis form fields. Please do not provide patient identifiable information.

For guidance on adequate endoscopy click here. For guidance on endoscopic follow-up and surveillance intervals click here.

Follow up plan post index endoscopy

Please provide information on the follow up plan created following the index endoscopy.

For guidance on endoscopic follow-up and surveillance intervals click here.

For guidance on endoscopic follow-up and surveillance intervals click here.

PEUGIC categorisation details

Please categorise the PEUGIC case.

Non-procedural factors contributing to PEUGIC

Please provide information on the non-procedural factors that may have contributed to the PEUGIC.

Patient outcomes

Please provide information on the outcome of the patient.

Discharging duty of candour

Please provide information on the duty of candour process.

For guidance on avoidability click here.

Determining level of harm is a judgment. Whenever there is uncertainty the case should be discussed anonymously with colleagues to determine what harm, if any, has been caused by the delayed diagnosis, or failure to prevent cancer.

For guidance on discharging duty of candour click here.

It is recommended that the case is discussed with the hospital team responsible for discharges of duty of candour.

Final comments

Please provide any appropriate further information or final comments.

Please do not provide patient identifiable information.